Eli Lilly & Co (LLY) Gets a Buy from Citi
I'm PortAI, I can summarize articles.
Meacham covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Amgen, and Vertex Pharmaceuticals. According to TipRanks, Meacham has an average return of 4.2% and a 55.14% success rate on recommended stocks. In addition to Citi, Eli Lilly & Co also received a Buy from Wells Fargo’s Mohit Bansal in a report issued on October 10. However, on October 1, HSBC maintained a Hold rating on Eli Lilly & Co (NYSE: LLY).
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments